Figure Legends
Figure 1. Individual site accuracy of TruGraf results (n=192) showing concordance between a TruGraf TX result and patient clinical phenotype at each of the seven study sites (Marsh CL, et al., Transplant Proc. 2019;51:722-728)
Figure 2. Suggested use of TruGraf for kidney transplant recipients in the first 5 years post-transplant. Frequency of testing and clinical use of results is based on expert opinion. TX = Transplant excellence, indicating immunological quiescence in the transplanted kidney; Not-Tx = abnormal result